Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of +20.00% and +9.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7h ago
Small and Micro-Cap Movers: Your Daily Digest of High-Impact News From High-Growth Companies Rising in Popularity
The only curated source of news from smaller, under-the-radar stocks in the hottest sectors ready to make a move, and the analysis and rumors from social media driving the price action.
Stocktwits Contributor·1y ago
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments
Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be life savers to millions needing better and more effective healthcare solutions.